To investigate whether PEPCK1 and FASN were involved in the suppressive effect of TRIM21 on hepatic glucose and lipid metabolic disorders, we injected Ad-PEPCK1 and/or Ad-FASN into HFD-fed mice with TRIM21 overexpression. The gene discussed is PCK1; the disease is Disorder of lipid metabolism.